CA
NZ
UK
AU
IND
US
Oil held its ground above $82 a barrel as traders balanced growing geopolitical risk against the absence of any confirmed large-scale disruption to physical crude supply. A fresh round of fighting in Lebanon, combined with attacks on commercial vessels navigating the Strait of Hormuz, …
President Donald Trump has directed the Pentagon to substantially cut back joint military exercises with South Korea, a longtime treaty ally, arguing the drills are costly and unnecessary given what he called a non-threatening posture from North Korea. The order came just hours ahead …
● Teads Holding shares changed hands near $0.59 to $0.67 in mid-August 2026, down roughly 60% over the past year.
● VolitionRx Limited filed its second-quarter 10-Q on August 13, 2026 and hosted anEarnings Callthe following morning.
● Vivos Therapeutics reported second-quarter 2026 results on August 14 showing 35% year-over-yearRevenuegrowth.
● An NYSE minimum-price compliance deadline looms this fall, adding listing pressure to the stock.
● Surf Air Mobility reported second-quarter 2026Revenueof $29.5 million on August 10, at the high end of its guided $27 million to $30 million range.
● Quantum-Si Incorporated reported second-quarter 2026 results on August 13 that beat thinWall StreetRevenueestimates.
● Skye Bioscience discontinued its Phase 2a CBeyond trial of nimacimab in obesity on August 14, 2026.
● Outlook Therapeutics won FDA approval for LYTENAVA (bevacizumab-vikg) on July 24, 2026, the first and only FDA-approved ophthalmic formulation of bevacizumab.
Please wait processing your request...